Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases

D. Marinova (Sofia, Bulgaria), D. Kachakova (Sofia, Bulgaria), D. Dimitrova (Sofia, Bulgaria), A. Lilov (Sofia, Bulgaria), E. Mekov (Sofia, Bulgaria), M. Mihailov (Sofia, Bulgaria), S. Giragosyan (Sofia, Bulgaria), Y. Slavova (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria), V. Youroukova (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), A. Mitkova (Sofia, Bulgaria), R. Kaneva (Sofia, Bulgaria), V. Mitev (Sofia, Bulgaria)

Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Session: Lung cancer: novel prognostic markers and scores
Session type: Thematic Poster
Number: 2795

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Marinova (Sofia, Bulgaria), D. Kachakova (Sofia, Bulgaria), D. Dimitrova (Sofia, Bulgaria), A. Lilov (Sofia, Bulgaria), E. Mekov (Sofia, Bulgaria), M. Mihailov (Sofia, Bulgaria), S. Giragosyan (Sofia, Bulgaria), Y. Slavova (Sofia, Bulgaria), D. Kostadinov (Sofia, Bulgaria), V. Youroukova (Sofia, Bulgaria), R. Petkov (Sofia, Bulgaria), A. Mitkova (Sofia, Bulgaria), R. Kaneva (Sofia, Bulgaria), V. Mitev (Sofia, Bulgaria). Expression analysis of miR-223 in plasma of patients with non-small cell lung cancer and other obstructive lung diseases. 2795

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: